Overall, our data suggest a regulatory pathway where Pgam5 modulates mitochondrial fission and mitophagy via Phb2, offering insights into potential therapeutic targets for hyperglycemia-induced cardiomyocyte dysfunction. The gene discussed is PHB2; the disease is Hyperglycemia.